Decreased Levels of Intrathecal Interleukin 1 Receptor Antagonist in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|12|5|314-317

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.12, Iss.5, 2001-07, pp. : 314-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreased α-Synuclein Serum Levels in Patients with Lewy Body Dementia Compared to Alzheimer’s Disease Patients and Control Subjects

By  

Dementia and Geriatric Cognitive Disorders, Vol. 31, Iss. 6, 2011-07 ,pp. : 413-416

Karger

Access to resources Recommend Favorite

Interleukin 1 Alpha Gene Polymorphism as a Susceptibility Factor in Alzheimer’s Disease and Its Influence on the Extent of Histopathological Hallmark Lesions of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 3, 2002-09 ,pp. : 123-127

Karger

Access to resources Recommend Favorite

Intrathecal Release of Nitric Oxide in Alzheimer’s Disease and Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 6, 2000-10 ,pp. : 322-326

Karger

Access to resources Recommend Favorite

Interaction between Poly(ADP-Ribose) Polymerase 1 and Interleukin 1A Genes Is Associated with Alzheimer’s Disease Risk

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 4, 2007-02 ,pp. : 215-218

Karger

Access to resources Recommend Favorite

Interleukin-1α –889 C/T Polymorphism in Turkish Patients with Late-Onset Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 1, 2009-01 ,pp. : 82-87

Karger

Access to resources Recommend Favorite